comparemela.com

Latest Breaking News On - Biomunex pharmaceuticals - Page 2 : comparemela.com

Onward Therapeutics Made a Second Strategic Equity Investment in Emercell for Their NK Cell Technology in Cancer Immunotherapy

EPALINGES, Switzerland and MONTPELLIER, France, June 20, 2022 /PRNewswire/ Onward Therapeutics SA (Onward Therapeutics) and Emercell SAS (Emerc.

T ai peiFrance generalSwitzerland generalPatrick hennoAlain herreraInstitute of regenerative medicineBiomunex pharmaceuticalsUniversity hospital centerOnward therapeuticsOnward therapeuticChimeric antigen receptorCancer de montpellierRegenerative medicineNatural killerOccitanie region

Biomunex appoints Dr Simon Plyte, PhD, as Chief Scientific Officer to boost clinical and business d

Dr. Simon Plyte will help Biomunex accelerate preclinical and early clinical development of bi- and multi-specific antibodies in the treatment of cancer and ensure evolution of the BiXAb® platformDr. Plyte will also join the scientific advisory.

United statesFrance generalUnited kingdomSimon plytePierre emmanuel gerardInstitut curieBoehringer ingelheim biberachOntario cancer institute torontoOlivier lantz institut curie clinical immunology laboratoryBoehringer ingelheimUniversity of kielUniversity of portsmouthLudwig institute for cancer research londonMatthias peipp head of division antibodyBiomunex pharmaceuticalsNerviano medical sciences

BioSpace Movers & Shakers, March 4

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

United statesFrance generalBerlin centerUniversity of pennsylvaniaSouth koreaSouth koreanJohann bauersachsTechnische universitAdamb hughesLiodmila tchistiakovaGerasimos filippatosEric durandJodi parramonAlethia youngJohn farquharBirgitte stephenson

Ichnos Sciences Welcomes Eugene Zhukovsky, PhD, as New Chief Scientific Officer

Press release content from PR Newswire. The AP news staff was not involved in its creation.

New yorkUnited statesEugene zhukovskyCyril kontoHead of communicationsPrnewswire ichnos sciences incIchnos sciencesZm scientificIchnos sciences incBiomunex pharmaceuticalsCorporate affairsBrandeis university walthamSciences incChief scientific officerChief technology officerScientific advisory

Ichnos Sciences Welcomes Eugene Zhukovsky, PhD, as New Chief Scientific Officer

/PRNewswire/ Ichnos Sciences Inc., a global biotechnology company developing innovative biologic treatments in oncology and autoimmune diseases, today.

New yorkUnited statesEugene zhukovskyCyril kontoHead of communicationsIchnos sciencesZm scientificIchnos sciences incBiomunex pharmaceuticalsCorporate affairsBrandeis university walthamChief scientific officerChief technology officerScientific advisoryBrandeis universityAntibody industry

vimarsana © 2020. All Rights Reserved.